Atlas Trials

Processa Pharmaceuticals

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Processa Pharmaceuticals

RecordFirmDate
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer (NCT06568692)Processa Pharmaceuticals2024-10-02
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis (NCT05270460)Processa Pharmaceuticals2022-03-09
A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors (NCT04861987)Processa Pharmaceuticals2021-06-18
A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica (NCT04800562)Processa Pharmaceuticals2021-04-12
A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica (NCT03698864)Processa Pharmaceuticals2018-11-07
Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to Trental® Administered to Healthy Subjects (NCT03836222)Processa Pharmaceuticals2018-02-26
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer (NCT03189914)Processa Pharmaceuticals2017-10-02

Track Processa Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.